Screening compound: InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3

Screening compound: InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3
Screening compound: InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T815-0692

Molecular Formula

C14H14N6O (C14 H14 N6 O)

Compound Name

1-methyl-3-{5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine-7-carbonyl}-1H-indazole

IUPAC name

1-methyl-3-{5H6H7H8H-[124]triazolo[43-a]pyrazine-7-carbonyl}-1H-indazole

SMILES

Cn1nc(C(N2Cc3nncn3CC2)=O)c2c1cccc2

InChI

InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3

InChI Key

ITQGXSCSRCGMCJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29027537

InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Fragments Library (11262 compounds)

Protein-Protein Interaction Library (218420 compounds)

TLR-8 ligands Library (674 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Female
  • Skin
  • Immune system
Structure:
  • Fragments
  • Cyclic compounds
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • Others

References: we are preparing a list of scientific research reports with InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3?
Check Price and Availability of InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C14H14N6O/c1-18-11-5-3-2-4-10(11)13(17-18)14(21)19-6-7-20-9-15-16-12(20)8-19/h2-5,9H,6-8H2,1H3 available by request